Literature DB >> 8854848

Delayed image of iodine-123 iomazenil as a relative map of benzodiazepine receptor binding: the optimal scan time.

Y Onishi1, Y Yonekura, F Tanaka, S Nishizawa, H Okazawa, K Ishizu, T Fujita, J Konishi, T Mukai.   

Abstract

"Delayed" single-photon emission tomograpic (SPET) images after an intravenous bolus injection of iodine-123 iomazenil have been used as a relative map of benzodiazepine receptor binding. We determined the optimal scan time for obtaining such a map and assessed the errors of the map. SPET and blood data from six healthy volunteers and five patients were used. A three-compartment kinetic model was employed in simulation studies and analyses of actual data. The simulation studies suggested that, in the normal brain, the scan time at which a single SPET image best represented the relative receptor binding was 3.0-3.5 h post-injection. This finding was supported by actual data from the volunteers. The simulation studies also suggested that the optimal scan time was not greatly changed by the variability of the input functions, and that the error in the SPET image contrast in the vicinity of the optimal scan time was not increased by changes in the tracer kinetics in the entire brain. The SPET image contrast in the patients at 3.0 h post-injection agreed well with the reference receptor binding estimated by kinetic analysis, with a mean error of 3.6%. These findings support the use of a single SPET image after bolus injection of [123I]iomazenil as a relative map of benzodiazepine receptor binding. For this purpose, a SPET scan time of 3.0-3.5 h post-injection is recommended.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8854848     DOI: 10.1007/bf01254474

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  32 in total

1.  123-I-iomazenil-SPECT in patients with focal epilepsies--a comparative study with 99mTc-HMPAO-SPECT, CT and MR.

Authors:  F J Ferstl; M Cordes; I Cordes; H Henkes; W Christe; H Eichstädt; G Barzen; B Schmitz; P H Hasler; P A Schubiger
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

2.  [A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 4)--Report on clinical usefulness in diagnosis of cerebrovascular diseases].

Authors:  K Torizuka; K Uemura; M Toru; Y Shinohara; T Nishimura; Y Yonekura; J Nakagawara; H Matsuda; F Sakai; K Matsuda; H Fukuyama; K Morimoto
Journal:  Kaku Igaku       Date:  1996-03

3.  Single photon emission tomography measurement of benzodiazepine receptor number and affinity in primate brain: a constant infusion paradigm with [123I]iomazenil.

Authors:  M Laruelle; A Abi-Dargham; Z Rattner; M S al-Tikriti; Y Zea-Ponce; S S Zoghbi; D S Charney; J Price; J J Frost; P B Hoffer
Journal:  Eur J Pharmacol       Date:  1993-01-05       Impact factor: 4.432

4.  Receptor binding characterization of the benzodiazepine radioligand 125I-Ro16-0154: potential probe for SPECT brain imaging.

Authors:  E W Johnson; S W Woods; S Zoghbi; B J McBride; R M Baldwin; R B Innis
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

5.  [Benzodiazepine receptor and cerebral blood flow in early Alzheimer's disease--SPECT study using 123I-iomazenil and 123I-IMP].

Authors:  S Kitamura; Y Koshi; T Komiyama; O Sakayori; Y Komaba; M Ohyama; M Mishina; T Tsuganesawa; A Terashi
Journal:  Kaku Igaku       Date:  1996-01

6.  SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates: I. Kinetic modeling of single bolus experiments.

Authors:  M Laruelle; R M Baldwin; Z Rattner; M S al-Tikriti; Y Zea-Ponce; S S Zoghbi; D S Charney; J C Price; J J Frost; P B Hoffer
Journal:  J Cereb Blood Flow Metab       Date:  1994-05       Impact factor: 6.200

7.  Carbon-11 and iodine-123 labelled iomazenil: a direct PET-SPET compari son.

Authors:  G Westera; A Buck; C Burger; K L Leenders; G K von Schulthess; A P Schubiger
Journal:  Eur J Nucl Med       Date:  1996-01

8.  123I-iomazenil: a quantitative study of the central benzodiazepine receptor distribution.

Authors:  R C Haldemann; I Bicik; A Pfeiffer; H G Wieser; P H Hasler; P Schubiger; G K von Schulthess
Journal:  Nuklearmedizin       Date:  1992-06       Impact factor: 1.379

9.  Registration of three-dimensional MR and PET images of the human brain without markers.

Authors:  I Kapouleas; A Alavi; W M Alves; R E Gur; D W Weiss
Journal:  Radiology       Date:  1991-12       Impact factor: 11.105

10.  Simple quantification of benzodiazepine receptor binding and ligand transport using iodine-123-iomazenil and two SPECT scans.

Authors:  Y Onishi; Y Yonekura; T Mukai; S Nishizawa; F Tanaka; H Okazawa; K Ishizu; T Fujita; H Shibasaki; J Konishi
Journal:  J Nucl Med       Date:  1995-07       Impact factor: 10.057

View more
  2 in total

1.  Atrophy of the corpus callosum associated with a decrease in cortical benzodiazepine receptor in large cerebral arterial occlusive diseases.

Authors:  H Yamauchi; H Fukuyama; Y Dong; H Nabatame; Y Nagahama; S Nishizawa; J Konishi; H Shio
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-03       Impact factor: 10.154

2.  Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding.

Authors:  G Northoff; R Steinke; C Czcervenka; R Krause; S Ulrich; P Danos; D Kropf; H Otto; B Bogerts
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-10       Impact factor: 10.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.